Profil
L.
Mary Smith served as Vice President-Product Development at United Therapeutics Corp.
from 2014 to 2016.
She then worked as Executive Vice President-Gene Therapy at Bamboo Therapeutics, Inc. from 2016 to 2017.
Currently, she is the Chief Development Officer at Springworks Therapeutics, Inc. since 2020.
Dr. Smith received her undergraduate and doctorate degrees from the University of New Hampshire.
Anciens postes connus de L. Smith
| Sociétés | Poste | Fin |
|---|---|---|
| SPRINGWORKS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 15/12/2020 |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops gene therapies for rare neuromuscular and central nervous system diseases | Corporate Officer/Principal | 01/08/2017 |
| UNITED THERAPEUTICS CORPORATION | Corporate Officer/Principal | 01/06/2016 |
Formation de L. Smith
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
United Therapeutics Corp.
United Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes products to address the unmet medical needs of patients with chronic & life-threatening conditions | Health Technology |
University of New Hampshire
University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops gene therapies for rare neuromuscular and central nervous system diseases | Health Technology |
Springworks Therapeutics, Inc.
Springworks Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes medicines for nervous system disorders | Health Technology |
















